Trials / Recruiting
RecruitingNCT06519162
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Chungnam National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
Detailed description
1. The investigators will recruit study participants aged 19 and older who have been diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic steatohepatitis, or liver abscess, along with their household members, and who have agreed to participate in this study at Chungnam National University Hospital. 2. The investigators collect and analyze blood and stool samples from the patients and their household members 3. Sampling Method: Non-Probability Samples 4. Study Population: Group of autoimmune hepatitis: patients with definite autoimmune hepatitis or their healthy households for controls Group of primary biliary cholangitis: patients with definite primary biliary cholangitis or their healthy households for controls Group of primary sclerosing cholangitis: patients with definite primary sclerosing cholangitis or their healthy households for controls Group of non-alcoholic steatohepatitis: patients with definite non-alcoholic steatohepatitis or their healthy households for controls Group of liver abscess: patients with definite liver abscess or their healthy households for controls.
Conditions
- Autoimmune Hepatitis
- Primary Sclerosing Cholangitis
- Non-Alcoholic Fatty Liver Disease
- Liver Abscess
- Primary Biliary Cirrhosis
Timeline
- Start date
- 2024-07-08
- Primary completion
- 2029-07-08
- Completion
- 2029-07-08
- First posted
- 2024-07-25
- Last updated
- 2026-03-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06519162. Inclusion in this directory is not an endorsement.